ENTITY

OBI Pharma Inc (4174 TT)

6

Analysis

Health Care • Taiwan

OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.

more

Refresh

Exchange Announcement • 15 Nov 2024 14:33

Obi Is Invited To Present The Current Development Status Of Its Products And Technology Platforms At The Investor Conference Hosted By Masterlink

Exchange Announcement • 12 Nov 2024 14:30

Announcement Of The Company'S Full Receipt Of Cash Capital Increase In 2024 And The Reference Date Of Capital Increase

Exchange Announcement • 05 Nov 2024 17:10

Announcement Of Calls On Unpaid Shares Of 2024 Cash Capital Increase

Exchange Announcement • 04 Nov 2024 15:33

Announcement Of The Consolidated Financial Statements For The Third Quarter Of 2024 Were Approved By The Board Of Directors.

Exchange Announcement • 24 Oct 2024 17:56

Announcement Of The Company’S Board Meeting Date To Approve 2024q3 Consolidated Financial Report

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x